|
Volumn 11, Issue 1, 2006, Pages 99-100
|
Comment: Mortality benefit of no-load clopidogrel in COMMIT: Not a surprise
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
CLOPIDOGREL;
FIBRINOGEN RECEPTOR ANTAGONIST;
FIBRINOLYTIC AGENT;
ACUTE HEART INFARCTION;
BLOOD CLOT LYSIS;
CLINICAL TRIAL;
CORONARY STENT;
DOSE RESPONSE;
DRUG POTENCY;
HEART MUSCLE REPERFUSION;
HUMAN;
MORTALITY;
NOTE;
PRIORITY JOURNAL;
ASPIRIN;
CLINICAL TRIALS;
DRUG THERAPY, COMBINATION;
HUMANS;
MYOCARDIAL INFARCTION;
PLATELET AGGREGATION INHIBITORS;
TICLOPIDINE;
|
EID: 33645720938
PISSN: 10742484
EISSN: None
Source Type: Journal
DOI: 10.1177/107424840601100110 Document Type: Note |
Times cited : (8)
|
References (5)
|